Radiation ExposureKidney and urinaryProcedure
What this study is
Fluoroscopy is performed when placing a lead during a sacral neuromodulation procedure. During lead placement, subjects will receive either conventional or experimental fluoroscopic settings. The radiation exposure will be compared between the two groups.
What's being tested
- Reduced radiation fluoroscopy
Intervention · PROCEDURE
- Conventional fluoroscopy
Intervention · PROCEDURE
Both interventions
See previous information about each arm
Study details
- Official title
- Reduction in Fluoroscopy Radiation Exposure During Lead Implantation for Sacral Neuromodulation: A Randomized Prospective Study
- Sponsor
- Loma Linda University
- Conditions
- Radiation Exposure · Overactive Bladder · Urge Incontinence · Urgency-frequency Syndrome
- Enrolling
- 44 people
- Starts
- 2026-01
- Est. completion
- 2026-12
- Design
- Open-label, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 89 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Patients undergoing lead implantation for sacral neuromodulation that have overactive bladder as defined by urinary urgency, frequency, nocturia with or without urgency incontinence.
You can't join if
- Neurogenic bladder, BMI >40, or peripheral neuropathy.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openLoma Linda University Health
Loma Linda, California, United States
- Forrest Jellison, MD · Contact909-558-8724fjellison@llu.edu
Recruiting
Study team
Sponsor
Loma Linda University
Study ID 5200182
Principal investigator
Forrest Jellison, MD
Loma Linda University
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.